Navigation Links
Report: Task Force to Recommend Against PSA Test
Date:10/7/2011

THURSDAY, Oct. 6 (HealthDay News) -- The U.S. Preventive Services Task Force is preparing to recommend that men no longer get screened for prostate cancer by undergoing prostate specific antigen -- or PSA -- testing, CNN reported Thursday evening, citing a "source privy to the task force deliberations."

The task force is the same group of independent medical experts that unleashed a storm of controversy in 2009 by recommending that women in their 40s didn't need regular mammograms.

According to CNN, the task force will recommend that the PSA blood test get a "D" rating, which means "there is moderate or high certainty that the service has no net benefit or that the harms outweigh the benefits," according to the group's website.

CNN said the task force recommendation could come as soon as Tuesday, followed by a comment period before the group issues a final recommendation.

A draft copy of a task force report scheduled to be released Monday will say that a review of studies indicates that the PSA blood test -- which measures the presence of prostate specific antigen, a protein produced by cells of the prostate gland -- results in "small or no reduction" in prostate cancer deaths, the news network reported.

The test has been controversial for some time. Many doctors contend that the screen often uncovers tumors that are small and slow growing, and will never cause a man to die. On the other hand, treating the disease can often leave a patient impotent or incontinent.

Some prostate cancer patients were disappointed with the task force's decision.

A spokesman for the Prostate Cancer Foundation, Dan Zenka, described the proposed recommendation as "a tremendous mistake. You're talking to someone whose life was saved by [the PSA test]," CNN reported.

But Dr. Kenneth Lin, senior author of the paper due to be released Monday, said he believes PSA testing does more harm than good, the news network reported.

"Maybe you should get tested if you have this horrible family history where everyone gets prostate cancer before the age of 50. But for most men, testing is harmful," he said.

The U.S. Preventive Services Task Force is an independent panel of experts in prevention and evidence-based medicine and consists of primary care doctors, such as internists, pediatricians, family physicians, gynecologists/obstetricians, nurses, and health behavior specialists, according to the organization's website.

The task force conducts scientific evidence reviews of a broad range of clinical preventive health care services (such as screening, counseling, and preventive medications) and develops recommendations for primary care clinicians and health systems.

According to the American Cancer Society, prostate cancer is the most common type of cancer found in American men, other than skin cancer. It's the second leading cause of cancer death in men, behind only lung cancer.

The cancer society estimates that there are approximately 240,890 new cases of prostate cancer diagnosed each year, and about 34,000 men die from the disease annually.

More information

To learn more, visit the American Cancer Society.

SOURCES: CNN; American Cancer Society; U.S. Preventive Services Task Force website


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. New report: US investment in health research remains stagnant
2. Report: California Cities Have Worst Air Pollution in U.S.
3. Report: Hospital Errors May Be Far More Common Than Suspected
4. Report: Unemployment Adds 9 Million Uninsured in U.S.
5. Report: International collaboration between researchers results in greater recognition
6. New report: Employer health insurance premiums increased 41 percent from 2003 to 2009
7. Report: For every 1 homeless person in Canada, another 23 live in inadequate housing
8. New report: How will the affordable care act affect 15 million uninsured young adults?
9. American Stroke Association Late-Breaking Science News Report: Stroke Survivors Can Improve Functioning of Paralyzed Arm Years After Stroke
10. American Stroke Association Late-Breaking Science Report: Surgery, Stenting to Open Blocked Neck Arteries Similar in Safety, Efficacy, But Show Differences in Stroke, Heart Attack and Death Rates at Certain Ages
11. Pew Report: Louisiana Failing to Address Childrens Dental Health Crisis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... Datos Health , ... partnership with Med-e-Mass , the largest Electronic Medical Records (EMR) provider in South ... care plan incentives to a patient’s remote health progress, empowering the patient to take ...
(Date:4/26/2017)... ... April 26, 2017 , ... Infertility may be ... conditions and has helped many women become pregnant upon treating their diagnosis. ... and simple outpatient evaluations. We can provide the necessary information to diagnose ...
(Date:4/26/2017)... ... April 26, 2017 , ... Want to learn more about ... ) that demonstrates how this advanced plant breeding technology is a more efficient ... fewer resources. It highlights the business’ principles, research and collaboration efforts in this ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... is proud to announce that it has received 510(k) clearance from the U.S. ... Home and the MyoCycle Pro. , Both devices are stationary cycling systems that ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... have signed an agreement to be the preferred physical therapy provider for Derby ... returning them to Derby City CrossFit as quickly and effectively as possible, ProRehab’s ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 Research and ... Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, ... report to their offering. ... The global pharmacogenomics market was valued at US$ 7,167.6 Mn ... by 2024, expanding at a CAGR of 5.6% from 2016 ...
(Date:4/20/2017)... April 20, 2017 NeuroVive Pharmaceutical AB ... announced positive preclinical results demonstrating anti-fibrotic effects ... non-alcoholic steatohepatitis (NASH), in an additional well-validated ... NV556 has previously shown similar anti-fibrotic effects ... NeuroVive,s scientists present novel data demonstrating anti-fibrotic ...
(Date:4/19/2017)... 19, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the ... Co. Healthcare Investor Conference 2017 at the Sheraton Hotel in ... Chief Executive Officer of the Company is scheduled to present on ... Bear and the Chairman of the Board, Tony Holler ... ...
Breaking Medicine Technology: